Zacks Investment Management Increases Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Zacks Investment Management boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 7.4% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 60,578 shares of the company’s stock after acquiring an additional 4,168 shares during the quarter. Zacks Investment Management’s holdings in Option Care Health were worth $1,896,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the company. Blue Trust Inc. boosted its stake in shares of Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after purchasing an additional 377 shares during the period. GAMMA Investing LLC boosted its position in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares during the last quarter. Lindenwold Advisors INC grew its stake in shares of Option Care Health by 5.4% during the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock valued at $299,000 after acquiring an additional 489 shares in the last quarter. Trust Point Inc. increased its position in shares of Option Care Health by 2.6% during the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after acquiring an additional 622 shares during the last quarter. Finally, Nisa Investment Advisors LLC lifted its stake in shares of Option Care Health by 5.4% in the second quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock worth $376,000 after acquiring an additional 690 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Price Performance

OPCH opened at $23.24 on Tuesday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company’s 50-day moving average price is $26.04 and its 200 day moving average price is $28.66. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63. The firm has a market cap of $3.96 billion, a price-to-earnings ratio of 19.53, a price-to-earnings-growth ratio of 2.37 and a beta of 1.33.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on OPCH shares. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and lowered their price objective for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. UBS Group assumed coverage on shares of Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective on the stock. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Finally, JMP Securities increased their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $30.14.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.